Well said. Sessions comments should have been a catalyst to this stock. All bark-this is a response from the cannabis world: "If Rohrabacher-Blumenauer is re-authorized, which is likely but not certain, then Session's pronouncement today will be more bark than bite—regardless of the change in Policy the Federal government won't permitted to pursue medical marijuana prosecutions unless there are gross violations by a marijuana operator, such as diversion of cannabis across state lines
If Rohrabacher-Blumenauer is not reauthorized then in theory the Department of justice could institute a complete crackdown on marijuana. As this amendment has been extended by Congress 7 times I am cautiously optimistic that it will be re-authorized and things will be business as usual."
News 
Market Data 
Discover 
